XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUE (Tables)
12 Months Ended
Oct. 31, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

Life Sciences and Applied MarketsAgilent CrossLabDiagnostics and GenomicsTotal
(in millions)
Year Ended October 31, 2021:
Americas$951 $758 $695 $2,404 
Europe658 613 417 1,688 
Asia Pacific1,214 829 184 2,227 
Total$2,823 $2,200 $1,296 $6,319 
Year Ended October 31, 2020:
Americas$784 $667 $517 $1,968 
Europe540 532 371 1,443 
Asia Pacific1,068 701 159 1,928 
Total$2,392 $1,900 $1,047 $5,339 
Year Ended October 31, 2019:
Americas$692 $664 $505 $1,861 
Europe551 522 368 1,441 
Asia Pacific1,059 654 148 1,861 
Total$2,302 $1,840 $1,021 $5,163 

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
Years Ended October 31,
202120202019
(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical$2,224 1,754 $1,604 
Chemical and Energy1,328 1,154 1,199 
Diagnostics and Clinical938 787 785 
Food601 517 486 
Academia and Government576 526 474 
Environmental and Forensics652 601 615 
Total$6,319 $5,339 $5,163 
Revenue by Type
Instrumentation$2,657 2,249 $2,150 
Non-instrumentation and other3,662 3,090 3,013 
Total$6,319 $5,339 $5,163 
Contract with Customer, Asset and Liability
The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the years ended October 31, 2020 and 2021:

Contract
Liabilities
(in millions)
Ending balance as of October 31, 2019$386 
Net revenue deferred in the period347 
Revenue recognized that was included in the contract liability balance at the beginning of the period(300)
Change in deferrals from customer cash advances, net of revenue recognized
Currency translation and other adjustments
Ending balance as of October 31, 2020$446 
Net revenue deferred in the period406 
Revenue recognized that was included in the contract liability balance at the beginning of the period(359)
Change in deferrals from customer cash advances, net of revenue recognized24 
Currency translation and other adjustments
Ending balance as of October 31,2021$519